Clinical Trials Directory

Trials / Unknown

UnknownNCT00038753

Vision In Preschoolers Study (VIP Study)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
National Eye Institute (NEI) · NIH
Sex
All
Age
36 Months – 59 Months
Healthy volunteers
Accepted

Summary

To identify vision-screening tests that can accurately predict those three- and four-year old preschoolers who would benefit from a comprehensive vision examination because of signs of amblyopia, strabismus, and/or significant refractive error.

Detailed description

The Vision In Preschoolers (VIP) Study is a multi-center, multidisciplinary, prospective clinical study to evaluate screening tests for identifying preschool children in need of comprehensive eye examinations. The primary goal of the VIP Study is to identify an effective and efficient battery of screening tests that has high sensitivity and specificity in identifying preschoolers in need of further evaluation for amblyopia, strabismus and/or significant refractive error. The VIP Study is designed in three-phases. Phase I activities will establish which screening tests perform well when administered by licensed eye care professionals (pediatric optometrists and pediatric ophthalmologists) in a population of 1000 Head Start preschoolers at high risk for the targeted vision disorders. Phase II activities will provide evaluation of the tests' performance when administered by pediatric nurses and lay people on a high risk population of 1000 Head Start preschoolers. Each child will be tested twice with each screening test - once by a pediatric nurse and once by a lay screener. Tests selected for Phase II will be determined by the outcome of Phase I. Phase III activities will evaluate the performance of the tests in identifying individuals with specific vision disorders in a general population of (6400) Head Start preschoolers. The category of screening personnel and the specific screening tests used in Phase III will be determined by the outcome of Phases I and II.

Conditions

Interventions

TypeNameDescription
PROCEDUREVision Screening

Timeline

First posted
2002-06-05
Last updated
2009-10-16

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00038753. Inclusion in this directory is not an endorsement.